I’ve had 4 cycles of revlimid, velcade and dexamethasone now. I guess the main side effect is neuropathy in my feet and fingertips. In my feet it is centered where my toes are connected, i.e., the balls. The sensitivity seems to worsen with each cycle. I didn’t experience anything else of consequence until the 4th cycle. I had diarrhea for a day and a half, not necessarily bad but annoying at best, The other thing that is really annoying is my feeling cold all the time, especially my feet. I have ordered some heated socks and am currently wearing thermal underwear.
- You are viewing a Navigating Care library resource.
- Go to Library

Regimen Information
For BTD, including Side Effects
BTD
Drugs in this Regimen:
How BTD chemotherapy is given and possible side effects.
BTD for the treatment of Multiple Myeloma
BTD is the acronym for a chemotherapy regimen used in the treatment of multiple myeloma
B = Velcade (bortezomib)
T = Thalomid (thalidomide)
D = dexamethasone
Chemotherapy is often given as a combination of drugs. Combinations usually work better than single drugs because different drugs kill cancer cells in different ways.
MOST COMMON SIDE EFFECTS OF BTD
-
Nausea & Vomiting
-
Diarrhea
-
Constipation
-
Neuropathy
For more information, see the 'Expert Resources' tab below.
Community Responses
Often, the most helpful information regarding treatment side effects comes not from clinical brochures, but rather from other patients like you. We've collected the most helpful community resources to help you prepare for the side effects and coping tips for your chemotherapy regimen.
What side effects did you experience while on this medication?
This discussion needs your voice!
What were the specific side effects that you experienced while taking this medication? How did you manage them?
What coping tips would you give to new patients on this regimen?
There are currently no answers to this question. Be the first to answer!
This discussion needs your voice!
What do you wish you had known before taking this medication? What information would you like to pass on to patients who are beginning this medication?